Eye infections, ranging from mild to severe, can affect various parts of the eye, including the conjunctiva, cornea, and eyelids. Common causes include bacteria, viruses, fungi, and parasites, with symptoms such as redness, itching, discharge, and blurred vision. Bacterial conjunctivitis, often referred to as "pink eye," is a prevalent type of eye infection, causing inflammation of the conjunctiva. Viral conjunctivitis, associated with viruses like adenovirus, can spread easily and is highly contagious. Corneal infections, known as keratitis, may result from injury, contact lens use, or exposure to contaminated water. Fungal keratitis, caused by fungi like Fusarium or Aspergillus, poses a serious threat to vision. Seeking prompt medical attention is essential to prevent complications and protect ocular health.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States